This tool looks for unlabeled Wikidata items in your language. It starts with a Wikidata item,
looks at all the associated Wikipedia pages, the links on all those pages, and lists the Wikidata items corresponding to the link targets.
Q2904204 - biopharmacy
Searching link targets on 1 Wikipedias...
| Item | Label [en] | Wikilabels | Link # |
|---|---|---|---|
Q1425425 [CC |  ] | drug tolerance | Accoutumance | 1 |
| Q389934 [CC | ] | agonist | Agoniste (biochimie) | 1 |
| Q1671731 [CC | ] | inverse agonist | Agoniste inverse | 1 |
| Q770260 [CC | ] | Partial agonist | Agoniste partiel | 1 |
| Q16833590 [CC | ] | area under the curve | Aire sous la courbe (pharmacocinétique) | 1 |
| Q410943 [CC | ] | antagonist | Antagoniste (biochimie) | 1 |
| Q461809 [CC | ] | bioavailability | Biodisponibilité (médecine) | 1 |
| Q864940 [CC | ] | bioequivalence | Bioéquivalence | 1 |
| Q1292017 [CC | ] | Good manufacturing practice | Bonnes pratiques de fabrication | 1 |
| Q243455 [CC | ] | medicinal chemistry | Chimie pharmaceutique | 1 |
| Q1163287 [CC | ] | clearance | Clairance (biologie) | 1 |
| Q286136 [CC | ] | half maximal effective concentration | Concentration efficace médiane | 1 |
| Q286779 [CC | ] | half maximal inhibitory concentration | Concentration inhibitrice médiane | 1 |
| Q898254 [CC | ] | dissociation constant | Constante de dissociation | 1 |
| Q47270 [CC | ] | half-life | Demi-vie | 1 |
| Q903071 [CC | ] | desiccation | Dessiccation | 1 |
| Q3028008 [CC | ] | dilution | Dilution | 1 |
| Q3030545 [CC | ] | medication dispensing | Dispensation (médecine) | 1 |
| Q1425437 [CC | ] | effective dose | Dose efficace médiane | 1 |
| Q680142 [CC | ] | acceptable daily intake | Dose journalière admissible | 1 |
| Q21136 [CC | ] | lethal dose | Dose létale | 1 |
| Q711849 [CC | ] | median lethal dose | Dose létale médiane | 1 |
| Q445205 [CC | ] | Measures of pollutant concentration | Dose sans effet observable | 1 |
| Q2047938 [CC | ] | adverse effect | Effet indésirable | 1 |
| Q1570182 [CC | ] | coating | Enrobage | 1 |
| Q244772 [CC | ] | filtration | Filtration | 1 |
| Q20659990 [CC | ] | Galénique | Galénique | 1 |
| Q81058 [CC | ] | homeopathy | Homéopathie | 1 |
| Q659446 [CC | ] | therapeutic index | Index thérapeutique | 1 |
| Q3241116 [CC | ] | Maximum Residue Limit | Limite maximale de résidus | 1 |
| Q723912 [CC | ] | freeze-drying | Lyophilisation | 1 |
| Q174858 [CC | ] | molecular modelling | Modélisation moléculaire | 1 |
| Q3026765 [CC | ] | neuropharmacology | Neuropharmacologie | 1 |
| Q3338704 [CC | ] | neurotoxicity | Neurotoxicité | 1 |
| Q1121713 [CC | ] | patient compliance | Observance thérapeutique | 1 |
| Q3363552 [CC | ] | No label in en! | Paramètres pharmacocinétiques | 1 |
| Q614304 [CC | ] | pharmacy | Pharmacie | 1 |
| Q155491 [CC | ] | clinical pharmacy | Pharmacie clinique | 1 |
| Q17994724 [CC | ] | formulation | Pharmacie galénique | 1 |
| Q158230 [CC | ] | pharmacoepidemiology | Pharmaco-épidémiologie | 1 |
| Q323936 [CC | ] | pharmacokinetics | Pharmacocinétique | 1 |
| Q725307 [CC | ] | pharmacodynamics | Pharmacodynamique | 1 |
| Q319616 [CC | ] | pharmacognosy | Pharmacognosie | 1 |
| Q1152227 [CC | ] | pharmacogenomics | Pharmacogénomique | 1 |
| Q1358521 [CC | ] | pharmacogenetics | Pharmacogénétique | 1 |
| Q128406 [CC | ] | pharmacology | Pharmacologie | 1 |
| Q186249 [CC | ] | pharmaceutics | Pharmacotechnie | 1 |
| Q1550789 [CC | ] | pharmacovigilance | Pharmacovigilance | 1 |
| Q3378619 [CC | ] | biopharmaceutical phase | Phase biopharmaceutique | 1 |
| Q3402384 [CC | ] | prescription of medications | Prescription de médicaments | 1 |
| Q1303150 [CC | ] | compounding | Préparation magistrale | 1 |
| Q1515727 [CC | ] | psychopharmacology | Psychopharmacologie | 1 |
| Q3130283 [CC | ] | list of purification methods in chemistry | Purification (chimie) | 1 |
| Q686886 [CC | ] | biological half-life | Période biologique | 1 |
| Q1251001 [CC | ] | dose–response relationship | Relation dose-effet | 1 |
| Q766383 [CC | ] | quantitative structure-activity relationship | Relation quantitative structure à activité | 1 |
| Q63391344 [CC | ] | antimicrobial resistance | Résistance aux antibiotiques | 1 |
| Q191618 [CC | ] | sterilization | Stérilisation (microbiologie) | 1 |
| Q912807 [CC | ] | active ingredient | Substance active (médicament) | 1 |
| Q3514829 [CC | ] | No label in en! | Tamisage | 1 |
| Q274160 [CC | ] | toxicity | Toxicité | 1 |
| Q7218 [CC | ] | toxicology | Toxicologie | 1 |
| Q1332167 [CC | ] | volume of distribution | Volume de distribution | 1 |
| Q7144988 [CC | ] | patient education | Éducation thérapeutique du patient | 1 |
| Q446142 [CC | ] | Serious adverse event | Événement indésirable grave | 1 |
| Q45959 [CC | ] | adverse drug reaction | Événement indésirable médicamenteux | 1 |